AZD1152 in Patients With Advanced Solid Malignancies-Study 3

Stopped Study is now terminated due to technical difficulties with administration of study drug in this patient population with this schedule

Conditions

• Solid Tumours

Interventions

• DRUG: AZD1152

Sponsor

AstraZeneca